November 13, 2013
Endo Pharmaceuticals Inc. and Actavis Inc. have been hit with two putative class actions in the past week in Pennsylvania and California federal courts over their patent settlement that allegedly delayed generic competition for Endo's pain relief patch Lidoderm.